Maximum quantity allowed is 999
请选择数量
CAS RN: 117048-59-6 | 产品编码: C2520
产品编码 | C2520 |
纯度/分析方法 | >98.0%(HPLC) |
分子式/分子量 | C__1__8H__2__0O__5 = 316.35 |
外观与形状(20°C) | 固体 |
储存温度 | 冷冻 (<0°C) |
储存在惰性气体下 | 存放于惰性气体之中 |
应避免的情况 | 光,空气,加热 |
包装和容器 | 250MG-Glass Bottle with Plastic Insert (查看图片) |
CAS RN | 117048-59-6 |
Reaxys-RN | 4786976 |
PubChem物质ID | 253660156 |
Merck Index (14) | 2494 |
MDL编号 | MFCD03453309 |
技术规格
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 98.0 area% |
NMR | confirm to structure |
物性(参考值)
熔点 | 83 °C |
GHS
相关法规
运输信息
HS编码* | 2909.50-000 |
应用
Combretastatin A4: Antimitotic Agent
Combretastatin A4 (CA-4), isolated from the African bush willow (Combretum caffrum), binds to tubulin dimers and prevents microtubule polymerization, resulting in mitotic arrest and apoptosis in endothelial cells. Concequentry, CA-4 shows strong cytotoxicity against a variety of tumor cells. Recently, various CA-4 analogs have been synthesized and evaluated for antitumor activity.
References
- Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4
- Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature
- G. G. Dark, S. A. Hill, V. E. Prise, G. M. Tozer, G. R. Pettit, D. J. Chaplin, Cancer Res. 1997, 57, 1829.
- Combretastatin A-4 phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues
- G. M. Tozer, V. E. Prise, J. Wilson, R. J. Locke, B. Vojnovic, M. R. L. Stratford, M. F. Dennis, D. J. Chaplin, Cancer Res. 1999, 59, 1626.
- Medicinal chemistry of combretastatin A4: Present and future directions
- Combretastatin A-4 analogs as anticancer agents
参考文献
产品文档 (部分产品的分析图谱无法提供,敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助,请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注:该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉,您搜索的分析图谱无法提供。